This panel discussion brings together global health and industry experts to explore how pharmaceutical manufacturing can remain resilient amid geopolitical instability and rapid technological change. Drawing on lessons from the COVID-19 pandemic, panelists will examine strategies to strengthen supply chain security, uphold regulatory compliance, and ensure the delivery of safe, high-quality medicines. With insights from the World Health Organization, national governments, and industry leaders at the forefront of these challenges, the discussion will address the urgent question: How can we ensure equitable, reliable, and quality production and supply of life-saving medicines for patients worldwide?
Join us for an insightful conversation on navigating the intersection of innovation, global health priorities, and systemic instability – defining the future of pharmaceutical manufacturing and operations.
:format(avif)/890x890/d5458549-550c-42f6-9644-35bb09953e52.avif)
:format(avif)/890x890/3329c37b-dc6e-4da0-99d6-86947e3274ae.avif)
:format(avif)/890x890/d176c6ec-17cd-44ab-bca4-9f70fc336bf1.avif)
:format(avif)/890x890/ca9c162c-f063-4349-8965-3b9a6539de88.avif)